Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
MDS 2022
EEC 2022
EAN 2022
AHS 2022
CMSC 2022
ESOC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Gennaro Pagano
2:26
Alpha-synuclein as a therapeutic target for Parkinson’s disease
Gennaro Pagano
• 5 Nov 2021
1:32
Searching for therapeutic targets for Parkinson’s disease
Gennaro Pagano
• 5 Nov 2021
1:46
Therapeutic approaches to target alpha-synuclein in Parkinson’s disease
Gennaro Pagano
• 5 Nov 2021
1:00
Future prospects in Parkinson’s disease
Gennaro Pagano
• 5 Nov 2021
1:24
PASADENA trial: prasinezumab in early Parkinson’s disease
Gennaro Pagano
• 10 Mar 2021
1:29
Prasinezumab: an anti-alpha-synuclein antibody in Parkinson’s disease
Gennaro Pagano
• 10 Mar 2021
1:49
Learnings from the PASADENA trial in Parkinson’s disease
Gennaro Pagano
• 10 Mar 2021
1:10
Age at onset and Parkinson’s disease progression
Gennaro Pagano
• 10 Mar 2021
1:24
The field of Parkinson’s disease research is expanding
Gennaro Pagano
• 10 Mar 2021
